Le PDG d'APOGEE vend des actions après une forte hausse du cours de l'action.

Résumé

Un article appartient à cette narration s'il traite de la vente d'actions par le PDG d'Apogee Therapeutics suite à une augmentation significative du cours de l'action.

Articles Liés

Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?

Yahoo Finance · Mar 30, 2026

Mixed

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Nasdaq · Mar 28, 2026

Bearish

Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's …

Nasdaq · Mar 26, 2026

Mixed

Sources

Eos Energy Director Buys $100,000 in Stock -- What Investors … Nasdaq

Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the … Yahoo Finance

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in … Nasdaq

Bicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks … Nasdaq

Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% … Nasdaq